Key Segments:
By Study Type
-
Feasibility and Pilot Study
-
Pivotal Study
-
FDA PMA Application
-
Post-Approval Study
By Study Design
-
Interventional
-
Observational
-
Expanded Access
By Indication
-
Cardiovascular Devices
-
Neurology Devices
-
Orthopedic Devices
-
Diagnostic Imaging
-
Anesthesia and Respiratory Devices
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include IQVIA, ICON, Medpace, NAMSA, Avania, Syneos Health, Parexel, and Fortrea, alongside device sponsors such as Medtronic, Abbott and Boston Scientific.
Key opportunities include decentralized and hybrid trials, real-world evidence platforms, AI-driven trial design, and emerging-market clinical research expansion.
The market is driven by rising medical device innovation, stricter clinical evidence requirements under FDA and EU MDR, chronic disease prevalence, and growing medtech venture investment.
The Pivotal Study segment dominated the Medical Device Clinical Trials Market, accounting for approximately 44% market share.
The North America region dominated the Medical Device Clinical Trials Market in 2025 with approximately 43.6% share, driven by a strong FDA framework, leading device manufacturers, and a deep network of clinical sites.
